Y mAbs Therapeutics (YMAB) — Tangible Net Worth Ratio
Y mAbs Therapeutics (YMAB) has a Tangible Net Worth Ratio of 97.5% as of June 2025. This metric is calculated by deducting intangible assets ($2.18 Million) from net assets ($87.49 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See working capital position of Y mAbs Therapeutics to evaluate short-term liquidity relative to the company's equity base.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Y mAbs Therapeutics Tangible Net Worth Ratio (2016–2024)
This chart shows how Y mAbs Therapeutics's Tangible Net Worth Ratio has changed across 9 annual periods from 2016 to 2024. As of June 2025, the ratio stands at 97.5%, reflecting net assets of $87.49 Million with intangible assets of $2.18 Million USD. See operational self-sufficiency of Y mAbs Therapeutics to measure how many days the company can operate on defensive assets alone.
Annual Tangible Net Worth Ratio for Y mAbs Therapeutics (2016–2024)
The table below presents the year-by-year Tangible Net Worth Ratio for Y mAbs Therapeutics from 2016 to 2024, covering 9 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see Y mAbs Therapeutics stock valuation.
| Year | Tangible NW Ratio | Net Assets (USD) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 97.5% | $92.00 Million | $2.28 Million | $119.90 Million | ▲ +0.1 pp |
| 2023 | 97.4% | $100.98 Million | $2.63 Million | $127.87 Million | ▲ +0.1 pp |
| 2022 | 97.3% | $109.22 Million | $2.99 Million | $141.46 Million | ▼ -1.8 pp |
| 2021 | 99.1% | $180.11 Million | $1.66 Million | $212.78 Million | ▼ -0.9 pp |
| 2020 | 100.0% | $105.84 Million | $0.00 | $132.05 Million | ▲ +0.0 pp |
| 2019 | 100.0% | $198.90 Million | $0.00 | $216.37 Million | ▲ +0.0 pp |
| 2018 | 100.0% | $140.53 Million | $0.00 | $151.92 Million | ▲ +0.0 pp |
| 2017 | 100.0% | $82.15 Million | $0.00 | $92.13 Million | ▲ +0.0 pp |
| 2016 | 100.0% | $12.06 Million | $0.00 | $17.26 Million | — |